SUPPERTIME MIXED INSULIN WITH DAYTIME SULFONYLUREA (SMIDS) FOR OBESE PERSONS WITH TYPE-II DIABETES

被引：0

作者：

HART, J ^{[1
]}

RIDDLE, M ^{[1
]}

机构：

[1] OREGON HLTH SCI UNIV,DEPT MED,PORTLAND,OR 97201

来源：

CLINICAL RESEARCH | 1990年 / 38卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

下载

页码：A121 / A121

页数：1

共 50 条

[1] COMBINED THERAPY FOR OBESE TYPE-2 DIABETES - SUPPERTIME MIXED INSULIN WITH DAYTIME SULFONYLUREA
RIDDLE, M
HART, J
BINGHAM, P
GARRISON, C
MCDANIEL, P
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (03): : 151 - 156
[2] AN EFFECTIVE NEW REGIMEN FOR TYPE-II DIABETES - BEDTIME INSULIN WITH DAYTIME SULFONYLUREA
RIDDLE, M
HART, J
BOUMA, D
PHILLIPSON, B
YOUKER, G
DIABETES, 1986, 35 : A66 - A66
[3] SUSTAINED EFFICACY OF BEDTIME INSULIN DAYTIME SULFONYLUREA (BIDS) FOR A SUBGROUP OF TYPE-II DIABETES
HART, J
RIDDLE, M
CLINICAL RESEARCH, 1988, 36 (01): : A153 - A153
[4] COMBINING INSULIN AND SULFONYLUREA - A THERAPEUTIC OPTION FOR TYPE-II DIABETES
RIDDLE, MC
POSTGRADUATE MEDICINE, 1992, 92 (02) : 89 - &
[5] EFFICACY OF BEDTIME NPH INSULIN WITH DAYTIME SULFONYLUREA FOR SUBPOPULATION OF TYPE-II DIABETIC SUBJECTS
RIDDLE, MC
HART, JS
BOUMA, DJ
PHILLIPSON, BE
YOUKER, G
DIABETES CARE, 1989, 12 (09) : 623 - 629
[6] SULFONYLUREA-INSULIN THERAPY IN TYPE-II DIABETES-MELLITUS
SHABAN, HM
TORRE, MS
LIPKIN, FR
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (04): : 328 - 329
[7] COMBINATION INSULIN-SULFONYLUREA THERAPY IN TYPE-II DIABETES-MELLITUS
ALLEN, BT
FEINGLOS, MN
SOUTHERN MEDICAL JOURNAL, 1987, 80 (10) : 1285 - 1289
[8] RELEVANCE OF SULFONYLUREA DOSIS IN THE COMBINED TREATMENT OF DIABETES TYPE-II WITH INSULIN AND SULFONYLUREAS
PASCHKE, R
SCHWEDES, U
SCHMEIDL, R
AUFENANGER, J
HOESL, W
KATTERMANN, R
USADEL, KH
INNERE MEDIZIN, 1987, 14 (01) : 3 - 9
[9] THE IMPACT OF SULFONYLUREA TREATMENT UPON THE MECHANISMS RESPONSIBLE FOR THE INSULIN RESISTANCE IN TYPE-II DIABETES
KOLTERMAN, OG
OLEFSKY, JM
DIABETES CARE, 1984, 7 : 81 - 88
[10] THE COMBINATION OF INSULIN AND SULFONYLUREA IN THE TREATMENT OF SECONDARY DRUG FAILURE IN PATIENTS WITH TYPE-II DIABETES
GROOP, L
HARNO, K
TOLPPANEN, EM
ACTA ENDOCRINOLOGICA, 1984, 106 (01): : 97 - 101

← 1 2 3 4 5 →